{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:06:54Z","timestamp":1788667614985,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1124\/mol.108.052084","type":"journal-article","created":{"date-parts":[[2008,11,8]],"date-time":"2008-11-08T01:54:59Z","timestamp":1226109299000},"page":"374-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Pharmacological Analysis of the Novel, Rapid, and Potent Inactivation of the Human 5-Hydroxytryptamine7 Receptor by Risperidone, 9-OH-Risperidone, and Other Inactivating Antagonists"],"prefix":"10.1016","volume":"75","author":[{"given":"Jessica A.","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Toohey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milt","family":"Teitler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.108.052084_REF1","doi-asserted-by":"crossref","first-page":"23422","DOI":"10.1016\/S0021-9258(19)49479-9","article-title":"Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase","volume":"268","author":"Bard","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.108.052084_REF2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00002512-200016060-00005","article-title":"Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia","volume":"16","author":"Bhana","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1124\/mol.108.052084_REF3","first-page":"193","article-title":"Pharmacokinetics of risperidone in chronic schizophrenic patients","volume":"30","author":"Borison","year":"1994","journal-title":"Psychopharmacol Bull"},{"key":"10.1124\/mol.108.052084_REF4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/10606820308245","article-title":"Unaltered agonist potency upon inducible 5-HT7a but not 5-HT4b receptor expression indicates agonist-independent association of 5-HT7a receptor and Gs","volume":"9","author":"Bruheim","year":"2003","journal-title":"Receptors Channels"},{"key":"10.1124\/mol.108.052084_REF5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000085897","article-title":"Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors","volume":"75","author":"Dautzenberg","year":"2005","journal-title":"Pharmacology"},{"issue":"Suppl 3","key":"10.1124\/mol.108.052084_REF6","first-page":"S80","article-title":"Pharmacological profile of risperidone","volume":"38","author":"Ereshefsky","year":"1993","journal-title":"Can J Psychiatry"},{"key":"10.1124\/mol.108.052084_REF7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)01115-1","article-title":"Functional characteristics of heterologously expressed 5-HT receptors","volume":"334","author":"Gerhardt","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.108.052084_REF8","first-page":"CD002306","article-title":"Risperidone versus other atypical antipsychotic medication for schizophrenia","volume":"3","author":"Gilbody","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/mol.108.052084_REF9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1185\/0300799009117010","article-title":"Focus on risperidone","volume":"16","author":"Green","year":"2000","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/mol.108.052084_REF10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2004.07.002","article-title":"Functional, molecular and pharmacological advances in 5-HT7 receptor research","volume":"25","author":"Hedlund","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.108.052084_REF11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/mol.108.052084_REF12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0028-3908(97)00036-1","article-title":"5-HT receptor classification and nomenclature: towards a harmonization with the human genome","volume":"36","author":"Hoyer","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.108.052084_REF13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/mol.105.021246","article-title":"Agonist-induced cell surface trafficking of an intracellularly sequestered D1 dopamine receptor homo-oligomer","volume":"70","author":"Kong","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.052084_REF14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2005.11.039","article-title":"Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT7 serotonin receptor","volume":"532","author":"Krobert","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.108.052084_REF15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s002100000369","article-title":"The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution","volume":"363","author":"Krobert","year":"2001","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.108.052084_REF16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/1568026023393796","article-title":"Molecular biology of serotonin receptors structure and function at the molecular level","volume":"2","author":"Kroeze","year":"2002","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/mol.108.052084_REF17","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1790-05.2005","article-title":"5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology","volume":"25","author":"Kvachnina","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/mol.108.052084_REF18","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1517\/14656566.1.7.1441","article-title":"Pharmacology and clinical experience with risperidone","volume":"1","author":"Love","year":"2000","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/mol.108.052084_REF19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0896-6273(93)90149-L","article-title":"A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms","volume":"11","author":"Lovenberg","year":"1993","journal-title":"Neuron"},{"key":"10.1124\/mol.108.052084_REF20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0026-895X(25)10354-4","article-title":"3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors","volume":"31","author":"Lyon","year":"1987","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.052084_REF21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.108.052084_REF22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(25)13616-X","article-title":"Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs","volume":"43","author":"Monsma","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.052084_REF23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0854.2007.00691.x","article-title":"Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization","volume":"9","author":"Ouedraogo","year":"2008","journal-title":"Traffic"},{"key":"10.1124\/mol.108.052084_REF24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00213-004-2057-6","article-title":"Stable expression of constitutively activated mutant H5HT6 and H5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs","volume":"179","author":"Purohit","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.108.052084_REF25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0163-7258(01)00169-3","article-title":"Multiplicity of mechanisms of serotonin receptor signal transduction","volume":"92","author":"Raymond","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.108.052084_REF26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Roth","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.108.052084_REF27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/bbrc.1993.1619","article-title":"A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of CAMP accumulation","volume":"193","author":"Ruat","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.108.052084_REF28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1124\/mol.108.052084_REF29","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1016\/S0021-9258(17)46830-X","article-title":"Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype","volume":"268","author":"Shen","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.108.052084_REF30","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1124\/mol.106.024612","article-title":"Risperidone irreversibly binds to and inactivates the H5-HT7 serotonin receptor","volume":"70","author":"Smith","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.052084_REF31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s002130000576","article-title":"Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia","volume":"153","author":"Spina","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.108.052084_REF32","first-page":"175","article-title":"Multiple serotonin receptor subtypes: molecular cloning and functional expression","volume":"8","author":"Teitler","year":"1994","journal-title":"Crit Rev Neurobiol"},{"key":"10.1124\/mol.108.052084_REF33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bjp.0701134","article-title":"Role of 5-HT7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat","volume":"121","author":"Terr\u00f3n","year":"1997","journal-title":"Br J Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24146901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24146901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.108.052084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:28:33Z","timestamp":1740047313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24146901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0026895X24146901"],"URL":"https:\/\/doi.org\/10.1124\/mol.108.052084","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Analysis of the Novel, Rapid, and Potent Inactivation of the Human 5-Hydroxytryptamine7 Receptor by Risperidone, 9-OH-Risperidone, and Other Inactivating Antagonists","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.108.052084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}